Tyrosine News and Research

RSS
Report highlights steady 26-year decline in overall cancer mortality

Report highlights steady 26-year decline in overall cancer mortality

Inhibition of a single enzyme may reduce heparin-induced thrombocytopenia

Inhibition of a single enzyme may reduce heparin-induced thrombocytopenia

Cancer drug shows promise in battling Parkinson’s disease

Cancer drug shows promise in battling Parkinson’s disease

Study shows nilotinib drug is safe and well tolerated in patients with Parkinson's disease

Study shows nilotinib drug is safe and well tolerated in patients with Parkinson's disease

The sympathetic nervous system can modulate action of defense cells in autoimmune disease

The sympathetic nervous system can modulate action of defense cells in autoimmune disease

Research reveals how skeletal muscle communicates with the brain regarding feeding behavior

Research reveals how skeletal muscle communicates with the brain regarding feeding behavior

Treatment combination improves survival in advanced HER2-positive breast cancer patients

Treatment combination improves survival in advanced HER2-positive breast cancer patients

Scientists highlight the benefits of Droplet Digital PCR technology at the 2019 ASH meeting

Scientists highlight the benefits of Droplet Digital PCR technology at the 2019 ASH meeting

New strategies needed to manage ibrutinib-related toxicities in CLL patients, study suggests

New strategies needed to manage ibrutinib-related toxicities in CLL patients, study suggests

Relapsed mantle cell lymphoma patients may benefit from CAR T-cell therapy

Relapsed mantle cell lymphoma patients may benefit from CAR T-cell therapy

Ibrutinib-based therapy provides superior clinical outcomes in majority of CLL patients

Ibrutinib-based therapy provides superior clinical outcomes in majority of CLL patients

New wearable sensor for non-invasive gout detection

New wearable sensor for non-invasive gout detection

FDA approves Ohio State-developed drug to treat patients with CLL and SCL

FDA approves Ohio State-developed drug to treat patients with CLL and SCL

Cancer drug shows promise in treating metabolic syndrome

Cancer drug shows promise in treating metabolic syndrome

Cardiac resynchronization therapy improves heart function in cancer survivors

Cardiac resynchronization therapy improves heart function in cancer survivors

Finding ways to stop cancer at its roots

Finding ways to stop cancer at its roots

Researchers make major breakthrough in cell signalling

Researchers make major breakthrough in cell signalling

NCCN ORP plans to support phase II randomized trial for lung cancer patients

NCCN ORP plans to support phase II randomized trial for lung cancer patients

Study reveals novel druggable driver gene in human gastrointestinal stromal tumors

Study reveals novel druggable driver gene in human gastrointestinal stromal tumors

Novel agent reduces buildup of toxic proteins in Parkinson's and Alzheimer's animal models

Novel agent reduces buildup of toxic proteins in Parkinson's and Alzheimer's animal models